Optimizing adherence to therapy in patients with non-specific back pain
- Authors: Dadasheva M.N1, Taranenko N.Y.2
-
Affiliations:
- N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Medincenter branch of GlavUpDK under MFA of Russian Federation
- Issue: Vol 18, No 9 (2016)
- Pages: 147-150
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94724
- ID: 94724
Cite item
Full Text
Abstract
Back pain is a common complaint among people of working age. To solve this problem, a comprehensive treatment is necessary. For the purpose of pain relief nonsteroidal anti-inflammatory drugs, muscle relaxants, vitamins of group B are usually appointed. The drugs of choice are non-steroidal anti-inflammatory drugs. Their application is limited due to the risk of adverse symptoms that occur in average 20-25% of cases, particularly in individuals with comorbid pathology. Often, because of the high risk of complications, patients stop taking their self-inflammatory drugs that reduces the effectiveness of treatment, leads to chronic disease. Strict compliance with all recommendations of the doctor, or patient compliance - a difficult task. The complexity of the implementation of all provisions of the doctor due to many factors. The aim of study was to investigate its own compliance in patients with non-specific back pain, determining factors to optimize adherence to therapy with nonsteroidal anti-inflammatory drugs.
Full Text
##article.viewOnOriginalSite##About the authors
M. N Dadasheva
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: donveles777@inbox.ru
д-р мед. наук, проф. каф. неврологии ФГБОУ ВО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
N. Yu Taranenko
Medincenter branch of GlavUpDK under MFA of Russian Federationневролог, Мединцентр, филиал ГлавУпДК при МИД РФ. Russian Federation, Moscow, 4-i Dobryninskii per., d. 4
References
- Боль: практическое руководство для врачей. Под ред. Н.Н.Яхно, М.Л.Кукушкина, М.: Издательство РАМН, 2012.
- Никифоров А.С., Коновалов А.Н., Гусев Е.И. Клиническая неврология. М.: Медицина, 2002.
- Breivik H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European J of Pain 2006; 10: 287-333.
- Manchikanti L, Singh V, Datta S et al. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12 (4): 35-70.
- Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. Клинические рекомендации. Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Соврем. ревматология. 2015; 1: 4-24.
- Barbanoj M, Antonijoan R, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin. Pharmacokinet 2001; 40 (4): 245-62.
- Beltrán J, Martín-Mola E, Figueroa M et al. Comparison of dexketoprofen trometamol and ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharmacol 1998; 38 (12): 745-805.
- Eken C, Serinken M, Elicabuk H et al. Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical low back pain in the emergency department: a randomized doubleblind controlled trial. Emerg Med J 2014; 3: 177-81.
